p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT-and ERK-dependent activation of NF-κB pathway N Tyagi, A Bhardwaj, AP Singh, S McClellan, JE Carter, S Singh Oncotarget 5 (18), 8778, 2014 | 135 | 2014 |
Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis R Kanchanapally, SK Deshmukh, SR Chavva, N Tyagi, SK Srivastava, ... International journal of nanomedicine, 531-541, 2019 | 124 | 2019 |
Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells … SK Deshmukh, SK Srivastava, A Bhardwaj, AP Singh, N Tyagi, ... Oncotarget 6 (13), 11231, 2015 | 119 | 2015 |
Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis S Arora, N Tyagi, A Bhardwaj, L Rusu, R Palanki, K Vig, SR Singh, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (5), 1265-1275, 2015 | 110 | 2015 |
p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling N Tyagi, S Marimuthu, A Bhardwaj, SK Deshmukh, SK Srivastava, ... Cancer letters 370 (2), 260-267, 2016 | 98 | 2016 |
Comparative analysis of the relative potential of silver, Zinc-oxide and titanium-dioxide nanoparticles against UVB-induced DNA damage for the prevention of skin carcinogenesis N Tyagi, SK Srivastava, S Arora, Y Omar, ZM Ijaz, ALG Ahmed, ... Cancer letters 383 (1), 53-61, 2016 | 89 | 2016 |
Exploiting nanotechnology for the development of microRNA-based cancer therapeutics N Tyagi, S Arora, SK Deshmukh, S Singh, S Marimuthu, AP Singh Journal of biomedical nanotechnology 12 (1), 28-42, 2016 | 76 | 2016 |
MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and-independent pathways SK Srivastava, A Bhardwaj, S Arora, N Tyagi, S Singh, J Andrews, ... British journal of cancer 113 (4), 660-668, 2015 | 76 | 2015 |
CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1 A Bhardwaj, SK Srivastava, S Singh, S Arora, N Tyagi, J Andrews, ... Oncotarget 5 (22), 11490, 2014 | 75 | 2014 |
Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances N Tyagi, M Tyagi, M Pachauri, PC Ghosh Tumor Biology 36, 8239-8246, 2015 | 72 | 2015 |
Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis SK Srivastava, A Bhardwaj, S Arora, N Tyagi, AP Singh, JE Carter, ... British journal of cancer 112 (11), 1772-1781, 2015 | 65 | 2015 |
Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages SK Deshmukh, N Tyagi, MA Khan, SK Srivastava, A Al-Ghadhban, ... Scientific reports 8 (1), 12000, 2018 | 61 | 2018 |
Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings SK Deshmukh, SK Srivastava, N Tyagi, A Ahmad, AP Singh, ... Carcinogenesis 38 (8), 757-765, 2017 | 61 | 2017 |
MYB is a novel regulator of pancreatic tumour growth and metastasis SK Srivastava, A Bhardwaj, S Arora, S Singh, S Azim, N Tyagi, JE Carter, ... British journal of cancer 113 (12), 1694-1703, 2015 | 56 | 2015 |
Development and Characterization of a Novel in vitro Progression Model for UVB-Induced Skin Carcinogenesis N Tyagi, A Bhardwaj, SK Srivastava, S Arora, S Marimuthu, SK Deshmukh, ... Scientific reports 5 (1), 13894, 2015 | 55 | 2015 |
Epigallocatechin gallate-gold nanoparticles exhibit superior antitumor activity compared to conventional gold nanoparticles: Potential synergistic interactions SR Chavva, SK Deshmukh, R Kanchanapally, N Tyagi, JW Coym, ... Nanomaterials 9 (3), 396, 2019 | 51 | 2019 |
ETV4 facilitates cell-cycle progression in pancreatic cells through transcriptional regulation of cyclin D1 N Tyagi, SK Deshmukh, SK Srivastava, S Azim, A Ahmad, A Al-Ghadhban, ... Molecular Cancer Research 16 (2), 187-196, 2018 | 42 | 2018 |
Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes SK Deshmukh, SK Srivastava, H Zubair, A Bhardwaj, N Tyagi, ... Cancer letters 396, 21-29, 2017 | 42 | 2017 |
Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: effect of monensin intercalated … N Tyagi, PC Ghosh European Journal of Pharmaceutical Sciences 43 (4), 343-353, 2011 | 42 | 2011 |
Biological basis of cancer health disparities: resources and challenges for research SK Deshmukh, S Azim, A Ahmad, H Zubair, N Tyagi, SK Srivastava, ... American journal of cancer research 7 (1), 1, 2017 | 34 | 2017 |